Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

CTech 24/7

Galmed

4 stories about Galmed

Israeli pharmaceutical company Galmed raises $18 million during trial of its main product
22.02.21|James SpiroThe Nasdaq-traded company has developed a drug to treat fatty liver
Biomed at the focus of new Israel-UAE business cooperation
25.10.20|CTechNew cross-business initiative is led by Tel-Aviv based consultancy firm Kamir Strategy and UAE-based PR firm Cosmopole
Liver Treatment Company Galmed Looking to Raise $75 Million in Public Offering
20.06.18|Dror ReichGalmed listed on Nasdaq in 2014. The company's stock jumped around 125% over the past two weeks following a successful study
Liver Treatment Company Galmed is Raising $6 Million in Direct Offering
04.04.18|Lilach BaumerThe company’s stock fell by 37% on Nasdaq since the beginning of the year, and by 66% since its Nasdaq listing in 2014

Twitter

Facebook

Rss

About CTech Terms of Use Privacy Policy

CTech 24/7

Galmed

Israeli pharmaceutical company Galmed raises $18 million during trial of its main product

Biomed at the focus of new Israel-UAE business cooperation

Liver Treatment Company Galmed Looking to Raise $75 Million in Public Offering

Liver Treatment Company Galmed is Raising $6 Million in Direct Offering